Distinguishing efficacy, individual effectiveness and population effectiveness of therapies

被引：44

作者：

Muñoz, A ^{[1
]}

Gange, SJ ^{[1
]}

Jacobson, LP ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA

来源：

关键词：

D O I：

10.1097/00002030-200004140-00020

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：754 / 756

页数：3

共 8 条

[1] AHDIEH L, 2000, IN PRESS AM J EPIDEM
[2] Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
Detels, R
Muñoz, A
McFarlane, G
Kingsley, LA
Margolick, JB
Giorgi, J
Scharager, LD
Phair, JP
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17): : 1497 - 1503
[3] Survival from early, intermediate, and late stages of HIV infection
Enger, C
Graham, N
Peng, Y
Chmiel, JS
Kingsley, LA
Detels, R
Munoz, A
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (17): : 1329 - 1334
[4] GAIL MH, 1995, AIDS CLIN TRIALS, P403
[5] MUNOZ A, 1995, AIDS CLIN TRIALS, P423
[6] Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials
Phillips, AN
Grabar, S
Tassie, JM
Costagliola, D
Lundgren, JD
Egger, M
[J]. AIDS, 1999, 13 (15) : 2075 - 2082
[7] Assessing the impact of highly active antiretroviral therapy on AIDS and death
Sabin, CA
[J]. AIDS, 1999, 13 (15) : 2165 - 2166
[8] Veugelers PJ, 1998, AM J EPIDEMIOL, V148, P487, DOI 10.1093/oxfordjournals.aje.a009674